✦ LIBER ✦

Drug treatment of Parkinson’s disease: Time for phase II

✍ Scribed by Benjamin Drukarch; Freek L van Muiswinkel

Book ID: 113994670
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 499 KB
Volume: 59
Category: Article
ISSN: 0006-2952
DOI: 10.1016/s0006-2952(99)00340-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New Drugs for the Treatment of Parkinson

New Drugs for the Treatment of Parkinson's Disease

✍ Peter A. LeWitt 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Costs of drug treatment in Parkinson's d

Costs of drug treatment in Parkinson's disease

✍ Dr. Richard C. Dodel; Karla M. Eggert; Marika S. Singer; Tobias E. Eichhorn; Oli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

## Abstract Parkinson's disease (PD) has a major socioeconomic impact on society. The chronic, progressive course of the disease, which often leads to severe disability, results in high expenses for the medical resources used for treatment, care, and rehabilitation of patients as well as reduced or

Drug treatments for the neuropsychiatric

Drug treatments for the neuropsychiatric complications of Parkinson’s disease

✍ Connolly, Barbara S; Fox, Susan H 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 920 KB

Drug selection and timing of initiation

Drug selection and timing of initiation of treatment in early Parkinson's disease

✍ Anthony H. V. Schapira; C. Warren Olanow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

Drug interactions in the treatment of Pa

Drug interactions in the treatment of Parkinson's disease

✍ W. H. Jost; C. Brück 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 215 KB

Quetiapine for the treatment of drug-ind

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Joseph H. Friedman; Carol Jacques; Michael Rosenfeld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views